Pages that link to "Q37928232"

The following pages link to Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future? (Q37928232):

Displaying 20 items.

• Cytotoxic chemotherapy: Still the mainstay of clinical practice for all subtypes metastatic breast cancer (Q26768140) (← links)
• The apoptotic effect of D Rhamnose β-hederin, a novel oleanane-type triterpenoid saponin on breast cancer cells (Q35113318) (← links)
• The proliferation rate paradox in antimitotic chemotherapy (Q35642841) (← links)
• The cost of cancer-related physician services to Medicare. (Q35652690) (← links)
• Advances in the management of metastatic breast cancer: options beyond first-line chemotherapy (Q35872691) (← links)
• Silibinin and Paclitaxel Cotreatment Significantly Suppress the Activity and Lung Metastasis of Triple Negative 4T1 Mammary Tumor Cell in Mice. (Q37618125) (← links)
• A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC). (Q38433690) (← links)
• Etirinotecan pegol for the treatment of breast cancer (Q38735361) (← links)
• Metastatic breast cancer: The Odyssey of personalization (Q38901163) (← links)
• Hypersensitivity reaction studies of a polyethoxylated castor oil-free, liposome-based alternative paclitaxel formulation (Q39215897) (← links)
• Safety and tolerability of eribulin mesylate in patients with pretreated metastatic breast cancer (Q40241837) (← links)
• Targeting mitotic exit with hyperthermia or APC/C inhibition to increase paclitaxel efficacy (Q42790803) (← links)
• Flaxseed Lignans Enhance the Cytotoxicity of Chemotherapeutic Agents against Breast Cancer Cell Lines MDA-MB-231 and SKBR3. (Q47206463) (← links)
• Cytotoxicity Study of Cyclopentapeptide Analogues of Marine Natural Product Galaxamide towards Human Breast Cancer Cells. (Q48095070) (← links)
• Novel triterpenoids isolated from raisins exert potent antiproliferative activities by targeting mitochondrial and Ras/Raf/ERK signaling in human breast cancer cells. (Q51672502) (← links)
• Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer. (Q55309854) (← links)
• Chemotherapy-resistant metastatic breast cancer (Q83974098) (← links)
• Highly durable response to capecitabine in patient with metastatic estrogen receptor positive breast cancer: A case report (Q90092522) (← links)
• TWIST1 Gene Expression as a Biomarker for Predicting Primary Doxorubicin Resistance in Breast Cancer (Q92670951) (← links)
• Protein Phosphatase 1H, Cyclin-Dependent Kinase Inhibitor p27, and Cyclin-Dependent Kinase 2 in Paclitaxel Resistance for Triple Negative Breast Cancers (Q94571091) (← links)